Grenfell-Gardner Jason

Teligent, Inc.

President & CEO, Director

Avg. Two Year Performance

32% Avg. Purchase Return 15% Compound

27% Avg. Sale Return 13% Compound

Holdings: 119.85K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions